Project

BIOHELIX II : The treatment of coronary artery lesions using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent

Aborted · 2013 until 2017

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Aborted
Start Date
2013
End Date
2017
Financing
Industry
Study Design
Prospective, non-randomized, multi-center, study performed in Europe with a minimum of 60 evaluable patients. A total of 80 patients will be enrolled to compensate for a 25% drop-out rate.
Keywords
Pro-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
Brief description/objective

Die Behandlung von koronaren Läsionen mit PRO-Kinetic Energy Kobalt-Chrom Metall Stent (BIOHELIX II)

Das primäre Ziel dieser Studie ist der Nachweis der klinischen Leistungsfähigkeit des PRO-Kinetic Energy Stents bei Patienten mit Atherosklerose in nativen Koronararterien